$4.6 B

GWPH Mkt cap, 15-Feb-2019

£8.2 M

GW Pharmaceuticals Revenue FY, 2017
GW Pharmaceuticals Gross profit (FY, 2017)4.7 M
GW Pharmaceuticals Gross profit margin (FY, 2017), %57%
GW Pharmaceuticals Net income (FY, 2017)-131.7 M
GW Pharmaceuticals EBITDA (FY, 2017)-147.8 M
GW Pharmaceuticals EBIT (FY, 2017)-153.3 M
GW Pharmaceuticals Cash, 30-Sep-2017241.2 M

GW Pharmaceuticals Income Statement

Annual

GBPFY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

5.0m3.1m2.0m5.7m11.8m24.1m30.7m29.6m33.1m27.3m30.0m28.5m10.3m8.2m

Revenue growth, %

10%(5%)(64%)

Cost of goods sold

82.0k277.0k254.0k249.0k433.0k752.0k1.3m839.0k1.3m2.1m2.6m2.7m3.5m

Gross profit

3.0m1.7m5.4m11.5m23.7m29.9m28.3m32.3m26.0m28.0m25.9m7.6m4.7m

Gross profit Margin, %

97%86%96%98%98%98%95%97%95%93%91%74%57%

Operating expense total

15.3m12.9m(13.2m)19.3m22.5m22.7m25.4m26.0m31.2m36.5m47.6m83.2m94.2m158.0m

EBITDA

(13.2m)(10.6m)1.5m5.2m2.9m1.8m(9.5m)(18.2m)(54.9m)(82.9m)(147.8m)

EBITDA margin, %

(232%)(90%)6%17%10%5%(35%)(61%)(192%)(804%)(1794%)

EBIT

(7.7m)(13.0m)(10.3m)(16.7m)(9.9m)14.9m(13.9m)(11.0m)1.0m4.5m2.3m1.0m(10.5m)(19.6m)(57.2m)(86.6m)(153.3m)

EBIT margin, %

(206%)(318%)750%(245%)(93%)4%15%8%3%(38%)(65%)(201%)(840%)(1861%)

Pre tax profit

(7.2m)(12.2m)(9.6m)(15.7m)(9.2m)(13.9m)(13.0m)(10.2m)1.2m4.6m2.5m1.2m(10.4m)(19.6m)(57.1m)(86.2m)(152.4m)

Income tax expense

347.0k942.0k1.6m2.1m1.7m2.0m2.0m2.0m353.0k37.0k221.0k1.2m5.8m4.9m12.5m22.5m20.7m

Net Income

(6.9m)(11.2m)(8.1m)(13.7m)(7.5m)(11.9m)(10.9m)(8.2m)1.5m4.6m2.7m2.5m(4.5m)(14.7m)(44.6m)(63.7m)(131.7m)

GW Pharmaceuticals Balance Sheet

Annual

GBPFY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

25.7m20.2m32.0m17.8m13.0m5.4m21.0m14.1m20.6m25.2m28.3m29.3m38.1m164.5m234.9m374.4m241.2m

Accounts Receivable

579.0k240.0k204.0k811.0k1.2m1.5m758.0k621.0k612.0k373.0k778.0k1.0m

Inventories

656.0k695.0k535.0k503.0k780.0k1.4m3.5m4.7m4.8m4.8m4.2m4.2m

Current Assets

26.6m21.5m34.2m20.2m15.8m24.9m24.3m17.1m22.3m27.2m32.0m35.3m47.4m176.4m255.1m404.5m276.7m

PP&E

740.0k1.0m802.0k1.0m723.0k952.0k1.1m1.1m1.9m1.6m1.9m2.4m5.5m11.6m28.7m38.9m43.7m

Goodwill

5.2m5.5m5.8m

Total Assets

34.4m29.1m41.3m27.1m22.1m31.1m30.3m23.4m29.4m34.0m39.1m42.9m58.9m193.5m289.7m453.2m332.9m

Accounts Payable

1.2m1.9m2.0m1.7m1.6m2.5m2.0m3.0m2.5m4.6m2.4m4.1m3.4m2.3m3.8m3.4m5.8m

Current Liabilities

1.8m3.3m4.0m3.6m3.4m5.4m7.6m9.8m9.1m9.7m10.0m11.6m12.7m17.3m27.8m35.0m36.5m

Non-Current Liabilities

20.0k56.0k318.0k69.0k22.0k10.6m17.3m15.4m13.5m11.6m11.4m10.1m10.8m17.6m16.7m19.7m18.3m

Total Liabilities

1.8m3.3m4.3m3.7m3.4m16.0m24.9m25.2m22.7m21.3m21.5m21.7m23.5m34.9m44.5m54.7m54.7m

Additional Paid-in Capital

96.0k100.0k110.0k111.0k114.0k120.0k120.0k121.0k129.0k131.0k133.0k133.0k178.0k237.0k261.0k302.0k304.0k

Retained Earnings

(6.9m)(11.2m)(8.1m)(13.7m)(7.5m)(11.9m)(10.9m)(8.2m)1.5m4.6m2.7m2.5m(4.5m)(14.7m)(44.6m)(63.7m)(131.7m)

Total Equity

32.6m25.8m37.0m23.5m18.7m15.1m5.3m(1.7m)6.7m12.7m17.7m21.2m35.4m158.6m245.3m398.5m278.2m

Financial Leverage

1.1 x1.1 x1.1 x1.2 x1.2 x2.1 x5.7 x-13.6 x4.4 x2.7 x2.2 x2 x1.7 x1.2 x1.2 x1.1 x1.2 x

GW Pharmaceuticals Cash Flow

Annual

GBPFY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(6.9m)(11.2m)(8.1m)(13.7m)(7.5m)(11.9m)(10.9m)(8.2m)1.5m4.6m2.7m2.5m(4.5m)(14.7m)(44.6m)(63.7m)(131.7m)

Cash From Operating Activities

6.3m10.4m8.6m16.4m10.0m3.3m(1.5m)7.4m1.2m4.3m2.4m1.8m(7.5m)(12.6m)(46.5m)(84.6m)(110.2m)

Cash From Financing Activities

30.5m4.4m19.3m108.0k2.8m8.1m62.0k104.0k6.3m628.0k1.4m73.0k18.3m144.3m128.4m206.8m(2.1m)

Net Change in Cash

1.2m279.0k1.1m1.7m1.7m2.5m2.5m6.9m6.5m4.6m3.1m814.0k8.7m124.5m64.2m113.5m(127.6m)

Income Taxes Paid

4.9m12.5m22.5m

GW Pharmaceuticals Ratios

GBPY, 2017

Revenue/Employee

16.6k

Financial Leverage

1.2 x
Report incorrect company information

GW Pharmaceuticals Employee Rating

3.516 votes
Culture & Values
3.5
Work/Life Balance
3.2
Senior Management
3.1
Salary & Benefits
3.2
Career Opportunities
3.1
Source